FARALLON CAPITAL MANAGEMENT LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 205 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2022$35,072,000
-65.9%
3,176,773
-48.6%
0.19%
-61.5%
Q1 2022$102,820,000
-11.1%
6,175,357
+1.9%
0.50%
-14.2%
Q4 2021$115,723,000
-12.1%
6,061,973
+13.5%
0.58%
-6.0%
Q3 2021$131,684,000
-3.6%
5,339,994
+1.7%
0.62%
+10.2%
Q2 2021$136,605,000
-9.2%
5,250,000
+10.5%
0.56%
-25.3%
Q1 2021$150,385,000
-46.0%
4,750,000
-20.8%
0.75%
-55.4%
Q4 2020$278,400,000
+42.0%
6,000,000
+0.8%
1.67%
+23.5%
Q3 2020$196,039,000
+9.2%
5,955,000
-8.9%
1.36%
-5.6%
Q2 2020$179,454,000
+4.3%
6,537,500
+13.7%
1.44%
-2.8%
Q1 2020$172,126,000
-0.5%
5,750,000
-8.0%
1.48%
+26.5%
Q4 2019$173,000,000
+57.8%
6,250,000
+3.7%
1.17%
+41.1%
Q3 2019$109,655,000
-21.9%
6,025,000
+5.2%
0.83%
-9.3%
Q2 2019$140,377,000
+157.8%
5,725,0000.0%0.91%
+123.2%
Q1 2019$54,445,000
+7.5%
5,725,0000.0%0.41%
+10.2%
Q4 2018$50,666,000
-4.7%
5,725,000
+21.2%
0.37%
+18.2%
Q3 2018$53,156,000
-6.2%
4,725,000
+6.8%
0.31%
-10.3%
Q2 2018$56,640,000
-19.2%
4,425,000
+6.6%
0.35%
-28.0%
Q1 2018$70,135,000
+369.6%
4,150,000
+122.3%
0.49%
+301.7%
Q4 2017$14,935,000
+126.7%
1,866,900
+119.6%
0.12%
+105.1%
Q3 2017$6,588,000850,0000.06%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,222,701$25,005,0008.92%
Broadfin Capital, LLC 4,894,361$55,062,0008.10%
GREAT POINT PARTNERS LLC 3,496,340$39,334,0006.13%
FRAZIER MANAGEMENT LLC 2,188,331$24,619,0004.51%
Prosight Management, LP 715,317$8,047,0004.49%
Avoro Capital Advisors LLC 8,662,720$97,456,0004.48%
QVT Financial LP 821,361$8,748,0002.26%
Perceptive Advisors 7,290,199$82,014,0002.19%
Rhenman & Partners Asset Management AB 1,290,495$14,518,0001.46%
EMORY UNIVERSITY 185,915$2,092,0001.37%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders